Low-risk patients with severe, symptomatic aortic stenosis show similar clinical outcomes and valve durability. HealthDay News — Seven-year follow-up data show that transcatheter aortic-valve ...

DENVER, CO — Two cardiac valve prostheses, similar in capability, offer the prospect of significant relief of mitral regurgitation (MR) via transcatheter mitral-valve replacement (TMVR) for patients ...

Transcatheter aortic valve replacement (TAVR) demonstrated better short-term outcomes, while surgical aortic valve replacement (SAVR) had better long-term outcomes. A recent study found that when it ...

The FDA PMA for JenaValve's Trilogy device for TAVR-AR comes months after a court struck down Edwards Lifesciences attempt to ...

While the first innovators in the area of minimally invasive cardiac procedures began introducing methods such as finger-fracture valvuloplasty as early as the 1920s — in the case of England’s Henry ...

A previous analysis in this trial showed that among patients with severe, symptomatic aortic stenosis who were at low surgical risk, the rate of the composite end point of death, stroke, or ...

Please provide your email address to receive an email when new articles are posted on . Edwards Lifesciences announced it received FDA approval for its transcatheter valve with adaptive prestent for ...

Edwards Lifesciences has claimed the FDA’s first approval of a transcatheter replacement implant for a leaky tricuspid heart valve, three months after garnering a green light in Europe. The Evoque, ...

Heart valves can be replaced with open heart surgery or with less invasive procedures that don’t require your chest to be opened. Known as transcatheter valve replacement, this type of procedure has ...

Transcatheter tricuspid valve implantation can be used in the NHS during the evidence generation period as an option to treat symptomatic severe tricuspid regurgitation when open surgical tricuspid ...